ESG & Responsibility
Regenerating Health. Responsibly.
Advanced medicine should be clinically responsible, ethically sourced, intelligently governed and capable of creating wider human value.
Patient-centred. Doctor-led. Evidence-aware. Built for accountable progress.
The Standard We Set
Progress is meaningful only when responsibility advances with it.
We do not separate innovation from oversight, or clinical ambition from patient dignity.
Regenerative medicine sits at the intersection of complex biology, developing evidence and deeply personal patient decisions. That demands more than a treatment menu. It demands a system for asking the right questions before, during and after care.
Our Framework
Four principles. One accountable clinical pathway.
This framework brings SCCM quality, clinical review, technology and social-impact commitments into one clear patient-facing standard.
Documented biological quality
Cell identity, source documentation, laboratory standards and batch-level quality information should be reviewed with care.
Suitability before treatment
Clinical decisions begin with records, history, goals, risks and an individualised doctor-led review.
AI assists. Clinicians decide.
Technology can organise complex information, but qualified professionals remain responsible for clinical interpretation.
Care that creates wider value
Operational discipline, responsible resource use and 2% for Care support a longer view of healthcare.
Patient Safety Pathway
From first records to responsible follow-up
A visible pathway helps patients understand what careful review should look like, without presenting every case as identical.
Records received
History, reports and goals collected securely.
Case organised
Information structured for clinical review.
Doctor review
Suitability, context and questions assessed.
Quality check
Relevant biological and laboratory records considered.
Shared plan
Options, limits and next steps explained.
Care delivery
Approved pathway coordinated by the clinical team.
Follow-up
Progress and ongoing care needs reviewed.
Responsibility In Practice
Clinical detail lives behind every principle.
The ESG hub stays concise. Patients who want depth can move into SCCM established authority pages without wading through duplicate content.
Ethical Sourcing
Cell quality, COA and laboratory standards
See how source documentation, certificates of analysis and laboratory quality information support a more informed review.
Explore biological quality standards
Responsible Technology
Clinical Intelligence, with human accountability
AI-assisted organisation can help surface relevant information. It does not diagnose, prescribe or replace professional judgment.
Explore the Clinical Intelligence PlatformYour Care Creates Care
An SCCM-funded allocation for patient access.
2% for Care links qualifying treatment revenue to a separately governed patient-access programme. The intention is simple: advanced care should help create carefully governed access for patients facing financial barriers, without adding a compulsory patient charge.
Environmental, Social & Governance
Commitments that mature into measurable practice.
We distinguish current practice, continuing commitments and programme implementation.
Clinical governance
- Doctor-led case review
- Documented cell-quality review
- Human oversight of AI-assisted workflows
- Clear patient education and consent
Responsible operations
- Reduce avoidable material waste
- Improve responsible procurement
- Strengthen resource measurement
- Prefer digital-first patient documentation
Patient access
- Maintain the 2% allocation model
- Separate clinical and financial decisions
- Protect applicant privacy and dignity
- Report verified outcomes transparently
Measurement
We report evidence, not ambition disguised as results.
Public figures will appear only after baselines, controls and verified reporting are established.
Qualifying revenue and SCCM allocations are tracked in the programme workflow.
Beneficiary activity will be reported in aggregate without exposing patient identities.
Environmental reporting will follow reliable measurement rather than estimates.
Questions, Answered Clearly
ESG and patient access FAQs
What does ESG mean in a regenerative medicine setting?
For SCCM, ESG connects responsible resource use, patient and community impact, clinical governance, biological quality, data responsibility and accountable technology.
Is SCCM claiming an ESG certification?
No. This page presents SCCM commitments and operating practices. Certifications or independently audited performance are stated only when documented.
What is 2% for Care?
It is an SCCM-funded patient-access allocation linked to qualifying treatment revenue, with no compulsory additional patient charge.
Does responsible AI make treatment decisions?
No. Technology may assist with organising information. Qualified clinicians remain responsible for professional interpretation and patient-specific decisions.
Responsible By Design
Begin with a careful clinical review.
Share the medical context first so the clinical team can assess what information is needed and whether a next step is appropriate.
See how this fits into a doctor-led review.
Use this page as part of a structured decision journey: clarify the patient goal, prepare records, compare options responsibly and move into Clinical Intelligence Review when ready.